Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	DNA-binding transcription factor activity, RNA polymerase II-specific	HIVEP3 SP100 ZNF610 BCL11B ZSCAN10 ZNF780A EGR4 SAMD11 KLF9 ZNF746 ZBTB40 ZBTB41 SIM1 CREB5 ZNF697	5.36e-05	1412	67	15	GO:0000981
GeneOntologyMolecularFunction	RNA polymerase II cis-regulatory region sequence-specific DNA binding	HIVEP3 ZNF610 BCL11B ZSCAN10 ZNF780A EGR4 KLF9 ZNF335 ZNF746 ZBTB41 ZNF649 CREB5 ZNF697	2.16e-04	1244	67	13	GO:0000978
GeneOntologyMolecularFunction	cis-regulatory region sequence-specific DNA binding	HIVEP3 ZNF610 BCL11B ZSCAN10 ZNF780A EGR4 KLF9 ZNF335 ZNF746 ZBTB41 ZNF649 CREB5 ZNF697	2.67e-04	1271	67	13	GO:0000987
GeneOntologyMolecularFunction	RNA polymerase II transcription regulatory region sequence-specific DNA binding	HIVEP3 ZNF610 BCL11B ZSCAN10 ZNF780A EGR4 KLF9 ZNF335 ZNF746 ZBTB41 SIM1 ZNF649 CREB5 ZNF697	2.89e-04	1459	67	14	GO:0000977
Domain	ZINC_FINGER_C2H2_2	HIVEP3 ZNF610 BCL11B ZSCAN10 ZNF780A EGR4 KLF9 ZNF335 ZNF746 ZBTB40 ZBTB41 POGZ ZNF649 CREB5 ZNF697	1.14e-07	775	69	15	PS50157
Domain	ZINC_FINGER_C2H2_1	HIVEP3 ZNF610 BCL11B ZSCAN10 ZNF780A EGR4 KLF9 ZNF335 ZNF746 ZBTB40 ZBTB41 POGZ ZNF649 CREB5 ZNF697	1.18e-07	777	69	15	PS00028
Domain	-	HIVEP3 ZNF610 BCL11B ZSCAN10 ZNF780A EGR4 KLF9 ZNF335 ZNF746 ZBTB40 ZBTB41 ZNF649 CREB5 ZNF697	1.50e-07	679	69	14	3.30.160.60
Domain	Znf_C2H2-like	HIVEP3 ZNF610 BCL11B ZSCAN10 ZNF780A EGR4 KLF9 ZNF335 ZNF746 ZBTB40 ZBTB41 POGZ ZNF649 CREB5 ZNF697	1.61e-07	796	69	15	IPR015880
Domain	Znf_C2H2	HIVEP3 ZNF610 BCL11B ZSCAN10 ZNF780A EGR4 KLF9 ZNF335 ZNF746 ZBTB40 ZBTB41 POGZ ZNF649 CREB5 ZNF697	1.86e-07	805	69	15	IPR007087
Domain	zf-C2H2	HIVEP3 ZNF610 BCL11B ZSCAN10 ZNF780A EGR4 KLF9 ZNF335 ZNF746 ZBTB40 ZBTB41 POGZ ZNF649 ZNF697	1.92e-07	693	69	14	PF00096
Domain	ZnF_C2H2	HIVEP3 ZNF610 BCL11B ZSCAN10 ZNF780A EGR4 KLF9 ZNF335 ZNF746 ZBTB40 ZBTB41 POGZ ZNF649 CREB5 ZNF697	1.95e-07	808	69	15	SM00355
Domain	Znf_C2H2/integrase_DNA-bd	HIVEP3 ZNF610 BCL11B ZSCAN10 ZNF780A EGR4 KLF9 ZNF335 ZNF746 ZBTB40 ZBTB41 ZNF649 CREB5 ZNF697	1.95e-07	694	69	14	IPR013087
Domain	TRPV1-4_channel	TRPV2 TRPV3	8.03e-05	4	69	2	IPR008347
Domain	DED_dom	CFLAR DEDD	2.79e-04	7	69	2	IPR001875
Domain	DED	CFLAR DEDD	2.79e-04	7	69	2	PF01335
Domain	DED	CFLAR DEDD	2.79e-04	7	69	2	PS50168
Domain	DED	CFLAR DEDD	2.79e-04	7	69	2	SM00031
Domain	DHC_N1	DNAH9 DNAH11	3.71e-04	8	69	2	PF08385
Domain	Dynein_heavy_dom-1	DNAH9 DNAH11	3.71e-04	8	69	2	IPR013594
Domain	Dynein_heavy_chain_D4_dom	DNAH9 DNAH11	1.19e-03	14	69	2	IPR024317
Domain	Dynein_HC_stalk	DNAH9 DNAH11	1.19e-03	14	69	2	IPR024743
Domain	Dynein_heavy_dom-2	DNAH9 DNAH11	1.19e-03	14	69	2	IPR013602
Domain	NPIP	NPIPB13 NPIPB5	1.19e-03	14	69	2	IPR009443
Domain	DHC_N2	DNAH9 DNAH11	1.19e-03	14	69	2	PF08393
Domain	MT	DNAH9 DNAH11	1.19e-03	14	69	2	PF12777
Domain	AAA_8	DNAH9 DNAH11	1.19e-03	14	69	2	PF12780
Domain	ATPase_dyneun-rel_AAA	DNAH9 DNAH11	1.19e-03	14	69	2	IPR011704
Domain	AAA_5	DNAH9 DNAH11	1.19e-03	14	69	2	PF07728
Domain	DHC_fam	DNAH9 DNAH11	1.37e-03	15	69	2	IPR026983
Domain	Dynein_heavy_dom	DNAH9 DNAH11	1.37e-03	15	69	2	IPR004273
Domain	Dynein_heavy	DNAH9 DNAH11	1.37e-03	15	69	2	PF03028
Domain	HECT	HECW1 HUWE1	4.45e-03	27	69	2	PF00632
Domain	HECTc	HECW1 HUWE1	4.45e-03	27	69	2	SM00119
Domain	HECT_dom	HECW1 HUWE1	4.45e-03	27	69	2	IPR000569
Domain	HECT	HECW1 HUWE1	4.45e-03	27	69	2	PS50237
Domain	zf-C2H2_6	ZSCAN10 ZNF780A ZNF746 ZBTB41 ZNF649	6.08e-03	314	69	5	PF13912
Domain	Ion_trans_dom	TRPV2 TRPV3 CACNA1G	8.66e-03	114	69	3	IPR005821
Domain	Ion_trans	TRPV2 TRPV3 CACNA1G	8.66e-03	114	69	3	PF00520
Pubmed	Polymorphisms of the TRPV2 and TRPV3 genes associated with fibromyalgia in a Korean population.	TRPV2 TRPV3	4.11e-06	2	71	2	27079220
Pubmed	Tcrδ translocations that delete the Bcl11b haploinsufficient tumor suppressor gene promote atm-deficient T cell acute lymphoblastic leukemia.	BCL11B ATM	4.11e-06	2	71	2	25486566
Pubmed	Zfp206 is a transcription factor that controls pluripotency of embryonic stem cells.	ZSCAN10 FGF8	4.11e-06	2	71	2	17628018
Pubmed	Developmental regulation and asymmetric expression of the gene encoding Cx43 gap junctions in the mouse limb bud.	FGF8 DNAH11	1.23e-05	3	71	2	9438343
Pubmed	Expression and distribution of three transient receptor potential vanilloid(TRPV) channel proteins in human odontoblast-like cells.	TRPV2 TRPV3	1.23e-05	3	71	2	28905239
Pubmed	Extent of intrinsic disorder and NMR chemical shift assignments of the distal N-termini from human TRPV1, TRPV2 and TRPV3 ion channels.	TRPV2 TRPV3	1.23e-05	3	71	2	35666427
Pubmed	A heat-sensitive TRP channel expressed in keratinocytes.	TRPV2 TRPV3	1.23e-05	3	71	2	12016205
Pubmed	ATM kinase activity modulates Fas sensitivity through the regulation of FLIP in lymphoid cells.	CFLAR ATM	1.23e-05	3	71	2	17932249
Pubmed	Nicotinic acid is a common regulator of heat-sensing TRPV1-4 ion channels.	TRPV2 TRPV3	2.46e-05	4	71	2	25752528
Pubmed	Clustering of Genetic Anomalies of Cilia Outer Dynein Arm and Central Apparatus in Patients with Transposition of the Great Arteries.	DNAH9 DNAH11	2.46e-05	4	71	2	36140829
Pubmed	FGF-induced vesicular release of Sonic hedgehog and retinoic acid in leftward nodal flow is critical for left-right determination.	FGF8 DNAH11	2.46e-05	4	71	2	15889083
Pubmed	Quantitative Real-Time PCR detection of TRPV1-4 gene expression in human leukocytes from healthy and hyposensitive subjects.	TRPV2 TRPV3	2.46e-05	4	71	2	18983665
Pubmed	Expression of transient receptor potential vanilloid (TRPV) families 1, 2, 3 and 4 in the mouse olfactory epithelium.	TRPV2 TRPV3	2.46e-05	4	71	2	19839244
Pubmed	ATM and SIRT6/SNF2H Mediate Transient H2AX Stabilization When DSBs Form by Blocking HUWE1 to Allow Efficient γH2AX Foci Formation.	ATM HUWE1	2.46e-05	4	71	2	26711340
Pubmed	A LewisX glycoprotein screen identifies the low density lipoprotein receptor-related protein 1 (LRP1) as a modulator of oligodendrogenesis in mice.	BCL11B LRP1	2.46e-05	4	71	2	23615909
Pubmed	Dissecting domain-specific evolutionary pressure profiles of transient receptor potential vanilloid subfamily members 1 to 4.	TRPV2 TRPV3	2.46e-05	4	71	2	25333484
Pubmed	Functional expression of transient receptor potential vanilloid-related channels in chronically hypoxic human pulmonary arterial smooth muscle cells.	TRPV2 TRPV3	2.46e-05	4	71	2	18787888
Pubmed	The E3 ubiquitin ligase Mule acts through the ATM-p53 axis to maintain B lymphocyte homeostasis.	ATM HUWE1	2.46e-05	4	71	2	22213803
Pubmed	2-aminoethoxydiphenyl borate is a common activator of TRPV1, TRPV2, and TRPV3.	TRPV2 TRPV3	4.09e-05	5	71	2	15194687
Pubmed	TRPV3 is a temperature-sensitive vanilloid receptor-like protein.	TRPV2 TRPV3	4.09e-05	5	71	2	12077606
Pubmed	DNAH11 Localization in the Proximal Region of Respiratory Cilia Defines Distinct Outer Dynein Arm Complexes.	DNAH9 DNAH11	4.09e-05	5	71	2	26909801
Pubmed	The arginine methyltransferase Carm1 is necessary for heart development.	CARM1 FGF8	4.09e-05	5	71	2	35736367
Pubmed	Identification and characterization of DEDD2, a death effector domain-containing protein.	CFLAR DEDD	4.09e-05	5	71	2	11741985
Pubmed	CFAP53 regulates mammalian cilia-type motility patterns through differential localization and recruitment of axonemal dynein components.	DNAH9 DNAH11	6.13e-05	6	71	2	33347437
Pubmed	Prediction of the coding sequences of unidentified human genes. VII. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro.	HECW1 ZFYVE26 HUWE1 DNAH9	6.28e-05	104	71	4	9205841
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	HIVEP3 ZNF610 HECW1 UTP4 ELAPOR1 SAFB2 EIF2AK1	6.70e-05	493	71	7	15368895
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	HIVEP3 PHLDB1 MROH1 TRIB3 POLE ZNF335 ZFYVE26 HUWE1 SH2B2 ANKRD16	8.01e-05	1105	71	10	35748872
Pubmed	Death effector domain-containing proteins DEDD and FLAME-3 form nuclear complexes with the TFIIIC102 subunit of human transcription factor IIIC.	CFLAR DEDD	8.57e-05	7	71	2	11965497
Pubmed	Mutations in DNAH17, Encoding a Sperm-Specific Axonemal Outer Dynein Arm Heavy Chain, Cause Isolated Male Infertility Due to Asthenozoospermia.	DNAH9 DNAH11	8.57e-05	7	71	2	31178125
Pubmed	Proinflammatory mediators modulate the heat-activated ion channel TRPV1 via the scaffolding protein AKAP79/150.	TRPV2 TRPV3	8.57e-05	7	71	2	18701070
Pubmed	USP7 Regulates Cytokinesis through FBXO38 and KIF20B.	ZNF780A POLE ZBTB40 DEDD	9.61e-05	116	71	4	30804394
Pubmed	Identification of the ligands of protein interaction domains through a functional approach.	CARM1 LRP1	1.47e-04	9	71	2	17124247
Pubmed	A proteomic analysis of ataxia telangiectasia-mutated (ATM)/ATM-Rad3-related (ATR) substrates identifies the ubiquitin-proteasome system as a regulator for DNA damage checkpoints.	ATM HUWE1	1.83e-04	10	71	2	17478428
Pubmed	Developmental nonlinearity drives phenotypic robustness.	TRIB3 FGF8	1.83e-04	10	71	2	29213092
Pubmed	Cusp patterning defect in Tabby mouse teeth and its partial rescue by FGF.	WNT10A FGF8	2.23e-04	11	71	2	10642790
Pubmed	ZBTB20 is crucial for the specification of a subset of callosal projection neurons and astrocytes in the mammalian neocortex.	BCL11B ZBTB40 ZBTB41	2.97e-04	63	71	3	34351428
Pubmed	Abnormal development of the apical ectodermal ridge and polysyndactyly in Megf7-deficient mice.	LRP1 FGF8	3.16e-04	13	71	2	16207730
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	ZSCAN10 ZNF780A SAFB2 ZBTB40 ZBTB41 GPR183 HUWE1 DEDD METTL17	3.53e-04	1084	71	9	11544199
Pubmed	Pogz deficiency leads to transcription dysregulation and impaired cerebellar activity underlying autism-like behavior in mice.	BCL11B POGZ	3.68e-04	14	71	2	33203851
Pubmed	Mitochondrial Stress Induces an HRI-eIF2α Pathway Protective for Cardiomyopathy.	TRIB3 EIF2AK1	3.68e-04	14	71	2	36154620
Pubmed	Splenic Dendritic Cells Survey Red Blood Cells for Missing Self-CD47 to Trigger Adaptive Immune Responses.	LRP1 GPR183	3.68e-04	14	71	2	26453377
Pubmed	Polynucleotide kinase-phosphatase enables neurogenesis via multiple DNA repair pathways to maintain genome stability.	BCL11B ATM	4.24e-04	15	71	2	26290337
Pubmed	Cdk12 Regulates Neurogenesis and Late-Arising Neuronal Migration in the Developing Cerebral Cortex.	BCL11B ATM	4.24e-04	15	71	2	27073218
Pubmed	Assembly and structure of Lys33-linked polyubiquitin reveals distinct conformations.	HECW1 HUWE1	4.84e-04	16	71	2	25723849
Pubmed	Heterogeneous nuclear ribonucleoprotein A3 controls mitotic progression of neural progenitors via interaction with cohesin.	BCL11B ATM	4.84e-04	16	71	2	32321712
Pubmed	Stalled replication forks within heterochromatin require ATRX for protection.	BCL11B ATM	4.84e-04	16	71	2	27171262
Pubmed	DNA-PKcs, ATM, and ATR Interplay Maintains Genome Integrity during Neurogenesis.	BCL11B ATM	4.84e-04	16	71	2	28123024
Pubmed	Armc5 deletion causes developmental defects and compromises T-cell immune responses.	ZBTB40 HUWE1	5.48e-04	17	71	2	28169274
Pubmed	Interactions of the Antiviral Factor Interferon Gamma-Inducible Protein 16 (IFI16) Mediate Immune Signaling and Herpes Simplex Virus-1 Immunosuppression.	CARM1 SP100 UTP4 NOL6 HUWE1	5.98e-04	332	71	5	25693804
Pubmed	Targeted tandem affinity purification of PSD-95 recovers core postsynaptic complexes and schizophrenia susceptibility proteins.	NSF LRP1	6.16e-04	18	71	2	19455133
Pubmed	The mammalian DM domain transcription factor Dmrta2 is required for early embryonic development of the cerebral cortex.	BCL11B FGF8	6.16e-04	18	71	2	23056351
Pubmed	Involvement of Atm and Trp53 in neural cell loss due to Terf2 inactivation during mouse brain development.	BCL11B ATM	6.16e-04	18	71	2	28620865
Pubmed	Genome-wide CRISPR-Cas9 Screen Identifies Leukemia-Specific Dependence on a Pre-mRNA Metabolic Pathway Regulated by DCPS.	MYO1G UTP4 NOL6 SAFB2 POGZ	6.66e-04	340	71	5	29478914
Pubmed	The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery.	SP100 UTP4 NOL6 SAFB2 LRP1 CPD POGZ CREB5 ZNF697	7.47e-04	1203	71	9	29180619
Pubmed	The functional interactome of PYHIN immune regulators reveals IFIX is a sensor of viral DNA.	BCL11B UTP4 NOL6 SAFB2 HUWE1	7.49e-04	349	71	5	25665578
Pubmed	A Wnt-bmp feedback circuit controls intertissue signaling dynamics in tooth organogenesis.	WNT10A FGF8	7.62e-04	20	71	2	22234613
Pubmed	Neurog1 and Neurog2 control two waves of neuronal differentiation in the piriform cortex.	BCL11B FGF8	7.62e-04	20	71	2	24403153
Pubmed	Human chromosome 7: DNA sequence and biology.	MYO1G HECW1 FASTK SND1-IT1 EIF2AK1 CREB5	8.00e-04	536	71	6	12690205
Pubmed	Snf2h Drives Chromatin Remodeling to Prime Upper Layer Cortical Neuron Development.	BCL11B ATM	8.41e-04	21	71	2	31680852
Pubmed	The N-Myc-DLL3 cascade is suppressed by the ubiquitin ligase Huwe1 to inhibit proliferation and promote neurogenesis in the developing brain.	BCL11B HUWE1	8.41e-04	21	71	2	19686682
Pubmed	HSF1 phosphorylation establishes an active chromatin state via the TRRAP-TIP60 complex and promotes tumorigenesis.	ZNF610 PHLDB1 NSF NOL6 SAFB2 CACNA1G EIF2AK1	8.75e-04	754	71	7	35906200
Pubmed	Trans-differentiation of outer hair cells into inner hair cells in the absence of INSM1.	BCL11B FGF8	9.24e-04	22	71	2	30305733
Pubmed	A missense mutation (R565W) in cirhin (FLJ14728) in North American Indian childhood cirrhosis.	UTP4 HSD11B2	9.24e-04	22	71	2	12417987
Pubmed	Lupus nephritis susceptibility loci in women with systemic lupus erythematosus.	HIVEP3 ZBTB41	1.01e-03	23	71	2	24925725
Pubmed	Tbx2 is a master regulator of inner versus outer hair cell differentiation.	BCL11B FGF8	1.01e-03	23	71	2	35508658
Pubmed	The inductive role of Wnt-β-Catenin signaling in the formation of oral apparatus.	WNT10A FGF8	1.01e-03	23	71	2	21600200
Pubmed	Mapping the expression of transient receptor potential channels across murine placental development.	TRPV2 TRPV3	1.10e-03	24	71	2	33884443
Pubmed	Non-EST-based prediction of novel alternatively spliced cassette exons with cell signaling function in Caenorhabditis elegans and human.	LRP1 CREB5	1.10e-03	24	71	2	17452356
Pubmed	The absence of Prep1 causes p53-dependent apoptosis of mouse pluripotent epiblast cells.	FGF8 ATM	1.10e-03	24	71	2	20826531
Pubmed	Embryonic cardiomyocytes can orchestrate various cell protective mechanisms to survive mitochondrial stress.	CFLAR TRIB3	1.10e-03	24	71	2	27106802
Pubmed	Neurogenesis requires TopBP1 to prevent catastrophic replicative DNA damage in early progenitors.	BCL11B ATM	1.10e-03	24	71	2	22522401
Pubmed	CARM1 is required for proper control of proliferation and differentiation of pulmonary epithelial cells.	CARM1 KLF9	1.10e-03	24	71	2	20530543
Pubmed	BTG4 is a meiotic cell cycle-coupled maternal-zygotic-transition licensing factor in oocytes.	RPL10L FGF8	1.10e-03	24	71	2	27065194
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	PHLDB1 HECW1 ZBTB40 CACNA1G	1.18e-03	225	71	4	12168954
Pubmed	International Union of Pharmacology. XLIX. Nomenclature and structure-function relationships of transient receptor potential channels.	TRPV2 TRPV3	1.20e-03	25	71	2	16382100
Pubmed	The ciliogenic transcription factor RFX3 regulates early midline distribution of guidepost neurons required for corpus callosum development.	BCL11B FGF8	1.20e-03	25	71	2	22479201
Pubmed	ATR maintains select progenitors during nervous system development.	BCL11B ATM	1.20e-03	25	71	2	22266795
Pubmed	The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation.	BCL11B POLE NOL6 POGZ HUWE1 CREB5	1.23e-03	583	71	6	29844126
Pubmed	System-Wide Modulation of HECT E3 Ligases with Selective Ubiquitin Variant Probes.	HECW1 HUWE1	1.29e-03	26	71	2	26949039
Pubmed	Ca2+ homeostasis maintained by TMCO1 underlies corpus callosum development via ERK signaling.	BCL11B FGF8	1.29e-03	26	71	2	35927240
Pubmed	The ubiquitin-dependent ATPase p97 removes cytotoxic trapped PARP1 from chromatin.	POLE UTP4 NOL6 POGZ HUWE1	1.37e-03	400	71	5	35013556
Pubmed	5-HT(6) receptor recruitment of mTOR as a mechanism for perturbed cognition in schizophrenia.	NSF ATM	1.40e-03	27	71	2	23027611
Pubmed	Twenty bone-mineral-density loci identified by large-scale meta-analysis of genome-wide association studies.	DCDC1 ZBTB40	1.40e-03	27	71	2	19801982
Pubmed	An introduction to TRP channels.	TRPV2 TRPV3	1.40e-03	27	71	2	16460286
Pubmed	Fgfr2b mediated epithelial-mesenchymal interactions coordinate tooth morphogenesis and dental trigeminal axon patterning.	WNT10A FGF8	1.50e-03	28	71	2	17951031
Pubmed	The tumor suppressor Nf2 regulates corpus callosum development by inhibiting the transcriptional coactivator Yap.	BCL11B FGF8	1.61e-03	29	71	2	25336744
Pubmed	Wnt regulates amino acid transporter Slc7a5 and so constrains the integrated stress response in mouse embryos.	TRIB3 FGF8	1.72e-03	30	71	2	31789450
Pubmed	Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes.	NSF POLE LRP1 ZBTB40 POGZ HUWE1 CREB5	1.82e-03	857	71	7	25609649
Pubmed	Tangential Intrahypothalamic Migration of the Mouse Ventral Premamillary Nucleus and Fgf8 Signaling.	FGF8 SIM1	1.84e-03	31	71	2	34095148
Pubmed	Liver X receptors and oxysterols promote ventral midbrain neurogenesis in vivo and in human embryonic stem cells.	LRP1 FGF8	1.84e-03	31	71	2	19796621
Pubmed	KDM2B regulates hippocampal morphogenesis by transcriptionally silencing Wnt signaling in neural progenitors.	BCL11B WNT10A	1.84e-03	31	71	2	37838801
Pubmed	Corticothalamic Projection Neuron Development beyond Subtype Specification: Fog2 and Intersectional Controls Regulate Intraclass Neuronal Diversity.	BCL11B KLF9	1.84e-03	31	71	2	27321927
Pubmed	TNF-α inhibits glucocorticoid receptor-induced gene expression by reshaping the GR nuclear cofactor profile.	PHLDB1 POLE FBF1 NOL6 ZFAND4 DNAH11	1.94e-03	638	71	6	31182584
Pubmed	The non-canonical BMP and Wnt/β-catenin signaling pathways orchestrate early tooth development.	WNT10A FGF8	1.96e-03	32	71	2	25428587
GeneFamily	Zinc fingers C2H2-type\|ZF class homeoboxes and pseudogenes	HIVEP3 ZNF610 BCL11B ZSCAN10 ZNF780A EGR4 KLF9 ZNF335 ZNF746 ZBTB40 ZBTB41 ZNF649 ZNF697	1.70e-07	718	55	13	28
GeneFamily	Caspases\|Death effector domain containing\|Ripoptosome\|Death inducing signaling complex	CFLAR DEDD	1.89e-04	7	55	2	1019
GeneFamily	Dyneins, axonemal	DNAH9 DNAH11	1.20e-03	17	55	2	536
GeneFamily	Transient receptor potential cation channels	TRPV2 TRPV3	3.26e-03	28	55	2	249
ToppCell	LPS-IL1RA+antiTNF-Hematopoietic_Mast-Mast_cells\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYO1G TBC1D10C CYSLTR2 BCL11B WNT10A GPR183	1.27e-07	146	71	6	a5c84ad44d6ffb25028a4fd5454fd5de81b16a5e
ToppCell	LPS-IL1RA+antiTNF-Hematopoietic_Mast\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYO1G TBC1D10C CYSLTR2 BCL11B WNT10A GPR183	1.27e-07	146	71	6	8133037881c15e75637fc616091a7055488dd5fc
ToppCell	LPS-IL1RA+antiTNF-Hematopoietic_Mast-Mast_cells-T-cells\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYO1G TBC1D10C CYSLTR2 BCL11B WNT10A GPR183	1.55e-07	151	71	6	b85a763459a0f019d1f9975d09b9f2247d62c9d3
ToppCell	E18.5-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MYO1G TBC1D10C SP100 CYSLTR2 TRPV2 SIM1	1.81e-07	155	71	6	d8e9f355ce933f6383c3d1e35ff55235a95c7fcd
ToppCell	facs-Heart-RV-3m-Lymphocytic-T_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TBC1D10C CYSLTR2 BCL11B EGR4 SAMD11 GPR183	2.71e-07	166	71	6	c0fd3f3f5c3412746da279b856af0d28b9b70c5d
ToppCell	facs-Heart-RV-3m-Lymphocytic-T_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TBC1D10C CYSLTR2 BCL11B EGR4 SAMD11 GPR183	2.71e-07	166	71	6	ac9b9df57d65ccbbf9ae3add50c5663efcd30dcb
ToppCell	LPS_only-Hematopoietic_Mast-Mast_cells-T-cells\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYO1G TBC1D10C CYSLTR2 BCL11B GPR183	4.20e-06	150	71	5	ccb782fbcb3122266354a112a9a850506664f44d
ToppCell	LPS_only-Hematopoietic_Mast-Mast_cells\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYO1G TBC1D10C CYSLTR2 BCL11B GPR183	4.20e-06	150	71	5	7290e9a812b1b2f919e67ccde0acf52687ab138f
ToppCell	LPS_only-Hematopoietic_Mast\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYO1G TBC1D10C CYSLTR2 BCL11B GPR183	4.20e-06	150	71	5	2c5078a1f769ba8153dee756b53d28eb7b434a96
ToppCell	E18.5-Immune-Immune_Lymphocytic_T/NK\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MYO1G TBC1D10C CYSLTR2 WNT10A SIM1	4.93e-06	155	71	5	efe69145910c5e049d0ed30699c26ef963e0a285
ToppCell	E18.5-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-NK\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MYO1G TBC1D10C SP100 CYSLTR2 SIM1	5.41e-06	158	71	5	5d926be5a0ebe8257cd552afa7844171f9ff01c0
ToppCell	facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	HECW1 POLE PCDH15 SIM1 DNAH9	6.11e-06	162	71	5	bf886e22ff2a20353499004b53f25fb9e6574896
ToppCell	facs-Heart-RV-3m-Lymphocytic\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TBC1D10C CYSLTR2 BCL11B EGR4 GPR183	6.88e-06	166	71	5	33c4876df43b4c1d100699bca47459918bd054d6
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	TBC1D10C ZNF610 BCL11B ATM GPR183	8.89e-06	175	71	5	06eace2e681980456299167b48bd49bcfea5e940
ToppCell	facs-BAT-Fat-24m-Epithelial-Epcam+\|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ELAPOR1 WNT10A HSD11B2 ERN2 ZFAND4	1.19e-05	186	71	5	b18d7398279a2d42414318aeb70514fd402f5a0a
ToppCell	wk_15-18-Hematologic_Lymphocytic-B-CD5-_Mature_B\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	MYO1G TBC1D10C SP100 GPR183 SH2B2	1.32e-05	190	71	5	ade43d1d1f8909b8526a23152acf3c26f160f836
ToppCell	NS-critical-d_16-33-Lymphoid-Treg\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	TBC1D10C BCL11B KLF9 ATM GPR183	1.54e-05	196	71	5	ad2d17cbfa1af4142f9cec2ea1a37d11d4b4151a
ToppCell	Parenchymal-10x3prime_v2-Epithelial-Epi_airway_ciliated-Deuterosomal\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	ZNF610 DCDC1 ELAPOR1 DNAH9 DNAH11	1.58e-05	197	71	5	861e8df9bd74dc5e17bafdc1fb3fef546753c73a
ToppCell	Bronchus_Control_(B.)-Immune-TX-B_cells\|Bronchus_Control_(B.) / Sample group, Lineage and Cell type	TBC1D10C SP100 TRPV3 ATM GPR183	1.61e-05	198	71	5	6231c44a909dd06f85c8210814e976a5f29148d0
ToppCell	TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligoastrocytoma-3\|TCGA-Brain / Sample_Type by Project: Shred V9	SAMD11 SYT6 PCDH15 ZBTB40	6.45e-05	135	71	4	3351e8b9e417397c5fa9f856184ff24ce1a27242
ToppCell	LPS-IL1RA-Hematopoietic_Mast-Mast_cells-T-cells\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TBC1D10C BCL11B TRPV2 GPR183	7.02e-05	138	71	4	10c263c58b83a018791f77098f18927d904cb13b
ToppCell	LPS-IL1RA-Hematopoietic_Mast\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TBC1D10C BCL11B TRPV2 GPR183	7.84e-05	142	71	4	f7d0d5ca9fc3dd929d4fdd59b71bfa623007e992
ToppCell	LPS-IL1RA-Hematopoietic_Mast-Mast_cells\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TBC1D10C BCL11B TRPV2 GPR183	7.84e-05	142	71	4	2a9a070e7c53ac593d46c6c5f6983f07d4413501
ToppCell	facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HECW1 POLE PCDH15 SIM1	8.50e-05	145	71	4	96712c68ab759d7ade0d912581a1a7c25dc6def8
ToppCell	367C-Lymphocytic-CD4_T-cell-Treg_cell_4\|367C / Donor, Lineage, Cell class and subclass (all cells)	TBC1D10C ELAPOR1 WNT10A OR2L13	8.50e-05	145	71	4	29422c908d58081e6a748e362a7ac41bf001444c
ToppCell	P15-Hematopoietic\|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	MYO1G TBC1D10C BCL11B GPR183	8.73e-05	146	71	4	2b3e6ff6069573ee213000aeab5de9a33afc1a99
ToppCell	LPS-antiTNF-Hematopoietic_Mast-Mast_cells\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TBC1D10C BCL11B TRPV2 GPR183	9.45e-05	149	71	4	59aa1f2a5cbeba64c4529fb05f544db17fd8b188
ToppCell	LPS-antiTNF-Hematopoietic_Mast\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TBC1D10C BCL11B TRPV2 GPR183	9.45e-05	149	71	4	1527cdd98a2734cbf8ce4c6170557280b71c55cb
ToppCell	Substantia_nigra-Hematopoietic-MICROGLIA\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	MYO1G GDPD3 POLE GPR183	9.69e-05	150	71	4	d44c02402e59a45e40b8fffbe71284032b5e7c92
ToppCell	Substantia_nigra-Hematopoietic-MICROGLIA-MI2(C1qb)\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	MYO1G GDPD3 POLE GPR183	9.69e-05	150	71	4	e020dbcf85c0ba7ad667b8bbeb6bbcfc135c9bb7
ToppCell	Substantia_nigra-Hematopoietic-MICROGLIA-MI2(C1qb)-MICROGLIA_Microglia.C1qb.Tmem119_(Microglia.C1qb.Tmem119)-\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	MYO1G GDPD3 POLE GPR183	9.69e-05	150	71	4	edbc1d29d213bf5908592135700e0d80e123c923
ToppCell	Substantia_nigra-Hematopoietic-MICROGLIA-MI2(C1qb)-MICROGLIA_Microglia.C1qb.Tmem119_(Microglia.C1qb.Tmem119)--\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	MYO1G GDPD3 POLE GPR183	9.69e-05	150	71	4	01c526e1e3007e71e416c317549fddd2919b14e9
ToppCell	Substantia_nigra-Hematopoietic-MICROGLIA-MI2(C1qb)-MICROGLIA_Microglia.C1qb.Tmem119_(Microglia.C1qb.Tmem119)\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	MYO1G GDPD3 POLE GPR183	9.69e-05	150	71	4	b7f5bf9af7ed50aad4da1c71d37b8b9709e6ce85
ToppCell	P15-Hematopoietic-Immune\|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	MYO1G TBC1D10C BCL11B GPR183	9.95e-05	151	71	4	a54045cac65a66197e3ad2b002fa6c511102834a
ToppCell	P15-Hematopoietic-Immune-immune_cell_unspecified\|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	MYO1G TBC1D10C BCL11B GPR183	9.95e-05	151	71	4	6b905d309f2a9b8828399b36f4942aec8696bee6
ToppCell	COVID-19-Epithelial_cells-Airway_mucous\|COVID-19 / group, cell type (main and fine annotations)	DCDC1 ELAPOR1 DNAH9 DNAH11	9.95e-05	151	71	4	8216462e723fec2797387929dde095370947e10a
ToppCell	343B-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0\|343B / Donor, Lineage, Cell class and subclass (all cells)	MYO1G HIVEP3 SP100 BCL11B	9.95e-05	151	71	4	78475027bba9e3026e42493fec8ea630972353bb
ToppCell	facs-Heart-RA-24m-Lymphocytic-T_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TBC1D10C CYSLTR2 BCL11B HECW1	1.10e-04	155	71	4	cc3fc379ea78742a216317054f336331f7c7a157
ToppCell	facs-Heart-RA-24m-Lymphocytic-T_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TBC1D10C CYSLTR2 BCL11B HECW1	1.10e-04	155	71	4	1900a76754e2a9c7117e531c5907b7942f72c4a6
ToppCell	PBMC-Control-Lymphocyte-T/NK-CD4+_T-Treg-Treg_4\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	FBF1 WNT10A GPR183 ZNF649	1.13e-04	156	71	4	84f01419d8c116714e8c8c857c4d153a755b7867
ToppCell	PBMC-Control-Lymphocyte-T/NK-CD4+_T-Treg-Treg_4\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	FBF1 WNT10A GPR183 ZNF649	1.13e-04	156	71	4	2285be9746d0d0f62a488b9c64fa67a834758dd7
ToppCell	PND28-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_prolif\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	RPL10L ZNF335 RTN4R ZBTB40	1.16e-04	157	71	4	6730b775308f45a2f3946016bdbb7f8e5b5efe49
ToppCell	Posterior_cortex\|World / BrainAtlas - Mouse McCarroll V32	HECW1 EGR4 RTN4R WNT10A	1.21e-04	159	71	4	18e9fe2efbe0bca7c3990f3b12b6f549e2c1263a
ToppCell	URO-Lymphocyte-T_NK-CD4_TEM\|URO / Disease, Lineage and Cell Type	BCL11B ELAPOR1 GPR183 ERN2	1.24e-04	160	71	4	e406f77b1c1a01d74f39ba65f99d5f8c7d75faf1
ToppCell	E18.5-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_mature\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	RPL10L MYO1G TBC1D10C SH2B2	1.30e-04	162	71	4	59f6a9005c4f22f084c25ea36f3cacce5144a9ae
ToppCell	COVID-19-kidney-Technical/muscle_(Imm)\|kidney / Disease (COVID-19 only), tissue and cell type	BCL11B PCDH15 ERN2 DNAH9	1.34e-04	163	71	4	19c28ce16a588a7f4a035c32726f6ccd67702b5b
ToppCell	Immune_cells-T_cells\|World / Lineage and Cell class	TBC1D10C SP100 BCL11B GPR183	1.34e-04	163	71	4	c5afdb5e7700bbd3ee8276910f9c4b4b3bcc3266
ToppCell	facs-Lung-EPCAM-24m-Lymphocytic-T_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TBC1D10C BCL11B SYT6 GPR183	1.37e-04	164	71	4	467ad12884b70d243988174ae960ee2b7b6cfb0c
ToppCell	facs-Lung-EPCAM-24m-Lymphocytic-Ly6g5b+_T\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TBC1D10C BCL11B SYT6 GPR183	1.37e-04	164	71	4	4e1861382c9e93856da19303474c8975c19706d2
ToppCell	facs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal-SPN_Neuron_STR\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BCL11B SAMD11 SYT6 ELAPOR1	1.40e-04	165	71	4	1b7dfa173e83aa8c46a3153a3261866c065c3b73
ToppCell	E18.5-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SP100 BCL11B TRPV2 GPR183	1.40e-04	165	71	4	0c80abf13409767825ef8a507b498afafa7e89c5
ToppCell	PND01-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_prolif\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	TBC1D10C SP100 GPR183 ZFAND4	1.40e-04	165	71	4	66f0364098d82629aa2ec1dfe0c5ad23de7c2c12
ToppCell	E18.5-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_mature\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SP100 BCL11B TRPV2 GPR183	1.40e-04	165	71	4	cced77f2d74b07010307d7f4788b8cf3fdaeb91a
ToppCell	facs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal-medium_spiny_neuron\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BCL11B SAMD11 SYT6 ELAPOR1	1.40e-04	165	71	4	b4f7d33af7d053ec07b01bd67d861600a9c4822e
ToppCell	facs-Lung-24m-Hematologic-lymphocytic-immature_innate_lymphoid_cell\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	TBC1D10C BCL11B SYT6 GPR183	1.47e-04	167	71	4	5d1919bea8e5a52ac6fc953caff15509b7142923
ToppCell	facs-Lung-24m-Hematologic-lymphocytic-immature_innate_lymphoid_cell-Ly6g5b+_T\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	TBC1D10C BCL11B SYT6 GPR183	1.47e-04	167	71	4	d8f497860d48342a3aaaad328f88e4d55ab4faeb
ToppCell	facs-Lung-18m-Hematologic-lymphocytic-CD4-positive,_alpha-beta_T_cell\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	TBC1D10C BCL11B ZSCAN10 GPR183	1.50e-04	168	71	4	68ee3b3b012b56584e313813feb16e632e3f72d2
ToppCell	droplet-Lung-1m-Hematologic-lymphocytic-CD4-positive,_alpha-beta_T_cell-CD4-positive,_alpha-beta_T_cell_l9\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	TBC1D10C BCL11B SAMD11 GPR183	1.50e-04	168	71	4	273168eefe0dae5494ac6ff5306bb307f06dc9c5
ToppCell	facs-Skin-Skin_Anagen-18m-Lymphocytic-T_cell\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO1G TBC1D10C SP100 CYSLTR2	1.53e-04	169	71	4	630d921aa8fb5681d06a4e09b833855c374be484
ToppCell	facs-Skin-Skin_Anagen-18m-Lymphocytic-nan\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO1G TBC1D10C SP100 CYSLTR2	1.53e-04	169	71	4	468284d4a3a0557aed04eadb1aba2317babc6904
ToppCell	facs-Skin-Skin_Anagen-18m-Lymphocytic\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO1G TBC1D10C SP100 CYSLTR2	1.53e-04	169	71	4	6f765e142d127545e622fe24b5287cd6e9706ccc
ToppCell	E18.5-Immune-Immune_Myeloid-Granulocytic-Basophil\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MYO1G TBC1D10C SAMD11 GPR183	1.53e-04	169	71	4	b23d0aaa2da333b9c69a7aee862d5a5d2a1bf79b
ToppCell	facs-Lung-24m-Hematologic-lymphocytic-CD8-positive,_alpha-beta_T_cell-CD8-positive,_alpha-beta_T_cell_l21\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	TBC1D10C BCL11B WNT10A GPR183	1.53e-04	169	71	4	dbf9b1d52b29bf4b60bd23012cc1ea82d344747f
ToppCell	droplet-Marrow-nan-3m-Myeloid-basophil\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SP100 KLF9 POLE CACNA1G	1.53e-04	169	71	4	5f5bec13208f4c3b6eacbba180c8a6402743b76e
ToppCell	E18.5-Immune-Immune_Myeloid-Granulocytic-Basophil-Basophil_mature\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MYO1G TBC1D10C SAMD11 GPR183	1.53e-04	169	71	4	83d1bcf33872b01ea9614f608a3e4ab30df25c7e
ToppCell	368C-Myeloid-Macrophage-SPP1+_Macrophage_2\|Macrophage / Donor, Lineage, Cell class and subclass (all cells)	PHLDB1 POLE ZNF335 NPIPB5	1.53e-04	169	71	4	ea600c63cf9572bc4b3cad6392f67bd0d92c7fc9
ToppCell	droplet-Liver-LIVER_NPC-30m-Lymphocytic\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TBC1D10C BCL11B WNT10A GPR183	1.57e-04	170	71	4	26178277bf9c7f2f06b5c0b03d4b69d78e9580c4
ToppCell	facs-Lung-18m-Hematologic-lymphocytic-CD4-positive,_alpha-beta_T_cell-CD4-positive,_alpha-beta_T_cell_l5\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	TBC1D10C BCL11B ZSCAN10 GPR183	1.57e-04	170	71	4	67e78e3c1d4cd3c6eaa5d0a9785b6cd8a3b08039
ToppCell	facs-Brain_Non-Myeloid-Cerebellum_-18m-Lymphocytic\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO1G TBC1D10C BCL11B GPR183	1.57e-04	170	71	4	c4f00c1acde1d3b521101e469101d10fd257653e
ToppCell	facs-Brain_Non-Myeloid-Cerebellum_-18m-Lymphocytic-nan\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO1G TBC1D10C BCL11B GPR183	1.57e-04	170	71	4	d3c1edaf0190d8927578043c372dba7477e75e14
ToppCell	facs-Liver-Non-hepatocytes-3m-Lymphocytic-mature_NK_T_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TBC1D10C CYSLTR2 BCL11B ZSCAN10	1.60e-04	171	71	4	d322cc042a6f4b4aa8ef80ae977edbce9e266d48
ToppCell	droplet-Lung-LUNG-30m-Lymphocytic-regulatory_T_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TBC1D10C CYSLTR2 BCL11B ELAPOR1	1.64e-04	172	71	4	4d04df9776394ea156ed5822f92ae74fdefbaa3d
ToppCell	facs-Heart-RV-18m-Lymphocytic-B_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TBC1D10C CYSLTR2 WNT10A GPR183	1.64e-04	172	71	4	2dcc9d67d6ecc35940eabbc8ed528f5f884f6976
ToppCell	droplet-Lung-LUNG-30m-Lymphocytic-Regulatory_T\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TBC1D10C CYSLTR2 BCL11B ELAPOR1	1.64e-04	172	71	4	3acf35b774ebc0f9e96299d0bd3e9d03bbf6b90c
ToppCell	facs-Heart-RV-18m-Lymphocytic-B_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TBC1D10C CYSLTR2 WNT10A GPR183	1.64e-04	172	71	4	64d2edbd8e2640b76225597883b1a524e6b1dd3b
ToppCell	facs-Heart-RV-18m-Lymphocytic\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TBC1D10C CYSLTR2 WNT10A GPR183	1.64e-04	172	71	4	d061ea21bee179df5a525842e9a48621a8e1461b
ToppCell	facs-Brain_Non-Myeloid-Cerebellum_-18m-Lymphocytic-CD8-positive,_alpha-beta_T_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO1G TBC1D10C BCL11B GPR183	1.68e-04	173	71	4	6397b3fa72e2621a9a0f27f49446de2d3a30e420
ToppCell	5'-Adult-LymphNode-Hematopoietic-T_cells-TRGV2_gdT\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CYSLTR2 ZNF780A TRPV2 ATM	1.68e-04	173	71	4	79d11f94a8f6a420c18c2fef0da77e9af3204765
ToppCell	facs-Brain_Non-Myeloid-Cortex-3m-Lymphocytic-CD8-positive,_alpha-beta_T_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO1G TBC1D10C SAMD11 GPR183	1.72e-04	174	71	4	6b362b8a934a4fe6a1dd867b7c448cb3fb3ffd6a
ToppCell	droplet-Lung-3m-Hematologic-lymphocytic-CD8-positive,_alpha-beta_T_cell-CD8-positive,_alpha-beta_T_cell_l9\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	TBC1D10C CYSLTR2 BCL11B GPR183	1.75e-04	175	71	4	f1d91cd49308cb501864cd16befaa43d6da828ca
ToppCell	Thalamus-Neuronal-Excitatory\|Thalamus / BrainAtlas - Mouse McCarroll V32	HECW1 RTN4R ELAPOR1 WNT10A	1.79e-04	176	71	4	d2bbf13d21fb7582d7e5f90cd61a4ebe1cfccd66
ToppCell	droplet-Bladder-nan-24m-Hematologic-nan\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO1G TBC1D10C CYSLTR2 GPR183	1.79e-04	176	71	4	0089b50d607f4d2f18639fab0f3fc779227baa7a
ToppCell	facs-Skin-Anagen-3m-Lymphocytic-T_cell\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO1G TBC1D10C SP100 TRPV2	1.83e-04	177	71	4	7853430fb0d1a18d835e8956777e0616c5d7d412
ToppCell	PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD4_T\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	TBC1D10C SP100 BCL11B GPR183	1.83e-04	177	71	4	13f22e578728be477b097889af483b1e3f3e18bb
ToppCell	facs-Skin-Anagen-3m-Lymphocytic\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO1G TBC1D10C SP100 TRPV2	1.83e-04	177	71	4	395f005f019aabb18738d3a10a04c37f216deda3
ToppCell	LPS-IL1RA+antiTNF-Lymphocytic_NKT\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYO1G TBC1D10C BCL11B GPR183	1.83e-04	177	71	4	f1efd9c3074d5635700fe7fbebf3dd0b1e0a84f1
ToppCell	facs-Skin-Anagen-3m-Lymphocytic-nan\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO1G TBC1D10C SP100 TRPV2	1.83e-04	177	71	4	9a5bf67a801826d094f679dd2189b62296c9694f
ToppCell	droplet-Lung-nan-21m-Lymphocytic-CD4-positive,_alpha-beta_T_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TBC1D10C BCL11B EGR4 GPR183	1.87e-04	178	71	4	c973818aa6b79127267c95294c09c70ab3e2fd07
ToppCell	facs-Heart-LA-18m-Lymphocytic-T_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TBC1D10C CYSLTR2 BCL11B GPR183	1.87e-04	178	71	4	d32b4e9c3d1f246ad49e2d8f6497989af68a6c00
ToppCell	Control-Lymphocytic_NKT-T_cells-T-cells\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYO1G TBC1D10C BCL11B GPR183	1.87e-04	178	71	4	910f8bea19d335455aba24e6a07b4834b709db5d
ToppCell	facs-Heart-LA-18m-Lymphocytic-T_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TBC1D10C CYSLTR2 BCL11B GPR183	1.87e-04	178	71	4	b7abf5656233e1a9cdbbe978dfa84d16f14b0be0
ToppCell	droplet-Lung-nan-21m-Lymphocytic-CD4+_T\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TBC1D10C BCL11B EGR4 GPR183	1.87e-04	178	71	4	ada794cb77e09faf80539616adeb32b38999f667
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_D_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EGR4 SYT6 PCDH15 CACNA1G	1.91e-04	179	71	4	7c8a2fa1326c73dc9e774df645b572864fd97133
ToppCell	PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD4_T-CD4_T_mature\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	TBC1D10C SP100 BCL11B GPR183	1.91e-04	179	71	4	8498f94202434b3cb5d84f1a37d3ad191baf664e
ToppCell	facs-Brain_Non-Myeloid-Hippocampus-24m-Lymphocytic-T_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO1G TBC1D10C UTP4 ZNF335	1.91e-04	179	71	4	30efe1f0394c0edb27b91890b5c4637b73cbc5ec
ToppCell	Control-Lymphocytic_NKT-T_cells\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYO1G TBC1D10C BCL11B GPR183	1.91e-04	179	71	4	d892d9496f1c33e23312092591eb2e968e736f7d
ToppCell	facs-Lung-18m-Hematologic\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	MYO1G TBC1D10C TRPV2 GPR183	1.91e-04	179	71	4	62fd60963203a3db98c83b19292c40cc4421cd94
ToppCell	facs-Diaphragm-Limb_Muscle-3m-Lymphocytic-T_cell\|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TBC1D10C CYSLTR2 BCL11B GPR183	1.91e-04	179	71	4	8bf04a7ad1b0be6722ebfdceba3f083f07bf96c5
ToppCell	droplet-Pancreas-Endocrine-21m-Hematologic-leukocyte\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO1G TBC1D10C SP100 GPR183	1.95e-04	180	71	4	83f9060dcf1d0ff8d2b2edc1841b2624b81c0eb3
ToppCell	facs-Limb_Muscle-Muscle_forelimb_and_hindlimb-18m-Lymphocytic-T_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CYSLTR2 BCL11B SAMD11 GPR183	1.95e-04	180	71	4	5fdd10ffdf49f0e818f865ca095a3882b35c640e
Drug	Cyanocobalamin [68-19-9]; Down 200; 3uM; MCF7; HT_HG-U133A	CFLAR KLF9 SAFB2 CPD POGZ ATM ERN2	1.89e-06	192	69	7	3252_DN
Drug	Moroxidine hydrochloride [3160-91-6]; Down 200; 19.2uM; MCF7; HT_HG-U133A	CFLAR SP100 KLF9 SAFB2 CPD ATM ERN2	2.09e-06	195	69	7	1527_DN
Drug	Ramipril [87333-19-5]; Down 200; 9.6uM; MCF7; HT_HG-U133A	RPL10L CFLAR FASTK POGZ ATM ERN2 DEDD	2.24e-06	197	69	7	3572_DN
Drug	Luteolin [491-70-3]; Up 200; 14uM; PC3; HT_HG-U133A	RPL10L CFLAR PHLDB1 BCL11B GDPD3 TRPV2 HSD11B2	2.39e-06	199	69	7	6658_UP
Drug	Basic Violet 11:1	CFLAR ATM	9.05e-06	2	69	2	CID000062265
Drug	Triamcinolone [124-94-7]; Up 200; 10.2uM; HL60; HG-U133A	CFLAR EGR4 FASTK KLF9 ZBTB40 CPD	2.28e-05	188	69	6	1395_UP
Drug	Dexamethasone acetate [1177-87-3]; Up 200; 9.2uM; HL60; HG-U133A	CFLAR FASTK KLF9 ZNF335 CPD DEDD	2.42e-05	190	69	6	1396_UP
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; HL60; HT_HG-U133A	HIVEP3 CFLAR TRIB3 FASTK ZNF335 NOL6	2.42e-05	190	69	6	1306_DN
Drug	zingerone	FASTK TRPV2 TRPV3	2.49e-05	19	69	3	CID000031211
Drug	Glafenine hydrochloride [65513-72-6]; Down 200; 9.8uM; MCF7; HT_HG-U133A	CFLAR SP100 SAFB2 ZBTB40 ATM DEDD	2.80e-05	195	69	6	7018_DN
Drug	Methylhydantoin-5-(D) [55147-68-7]; Down 200; 35uM; MCF7; HT_HG-U133A	HIVEP3 CFLAR PHLDB1 ATM EIF2AK1 ERN2	2.88e-05	196	69	6	3333_DN
Drug	Salbutamol [18559-94-9]; Down 200; 16.8uM; HL60; HT_HG-U133A	CARM1 FASTK KLF9 NOL6 SAFB2 ERN2	2.88e-05	196	69	6	2344_DN
Drug	Diloxanide furoate [3736-81-0]; Down 200; 12.2uM; MCF7; HT_HG-U133A	CFLAR PHLDB1 ZNF335 ZFYVE26 POGZ ATM	2.96e-05	197	69	6	5025_DN
Drug	Zoxazolamine [61-80-3]; Up 200; 23.8uM; PC3; HT_HG-U133A	RPL10L PHLDB1 BCL11B EGR4 SAFB2 LRP1	3.05e-05	198	69	6	6290_UP
Drug	Neostigmine bromide [114-80-7]; Down 200; 13.2uM; MCF7; HT_HG-U133A	RPL10L CFLAR KLF9 POGZ ATM ERN2	3.05e-05	198	69	6	3294_DN
Drug	Zoxazolamine [61-80-3]; Down 200; 23.8uM; MCF7; HT_HG-U133A	CFLAR SP100 PHLDB1 KLF9 SAFB2 ZFYVE26	3.05e-05	198	69	6	2625_DN
Drug	Folic acid [59-30-3]; Down 200; 9uM; PC3; HT_HG-U133A	RPL10L HIVEP3 SAFB2 CPD ERN2 DEDD	3.14e-05	199	69	6	5844_DN
Drug	Lysergol [602-85-7]; Down 200; 15.8uM; HL60; HT_HG-U133A	HIVEP3 FASTK SAFB2 ZBTB40 ZFYVE26 ERN2	3.14e-05	199	69	6	1325_DN
Drug	Trimethobenzamide hydrochloride [554-92-7]; Down 200; 9.4uM; MCF7; HT_HG-U133A	CFLAR SP100 PHLDB1 KLF9 SAFB2 ZBTB40	3.14e-05	199	69	6	1502_DN
Drug	Dizocilpine maleate [77086-22-7]; Up 200; 11.8uM; HL60; HG-U133A	CFLAR EGR4 FASTK TRPV2 ZBTB40 ATM	3.14e-05	199	69	6	1386_UP
Drug	Maprotiline hydrochloride [10347-81-6]; Down 200; 12.8uM; PC3; HT_HG-U133A	HIVEP3 SP100 SAFB2 LRP1 ATM ERN2	3.22e-05	200	69	6	6676_DN
Drug	Letrozole [112809-51-5]; Down 200; 14uM; MCF7; HT_HG-U133A	RPL10L HIVEP3 KLF9 ZBTB40 ATM ERN2	3.22e-05	200	69	6	4824_DN
Drug	Meclozine dihydrochloride [1104-22-9]; Up 200; 8.6uM; PC3; HT_HG-U133A	RPL10L SP100 HECW1 CACNA1G HUWE1 ERN2	3.22e-05	200	69	6	4646_UP
Drug	suberyldicholine	CFLAR NSF CHRNA4	3.94e-05	22	69	3	CID000123989
Drug	2-iodo-7,8-dibromodibenzo-p-dioxin	FASTK ATM	5.41e-05	4	69	2	CID000159485
Drug	PPAHV	TRPV2 TRPV3	9.00e-05	5	69	2	CID003035862
Drug	fenoxycarb	NSF LRP1 FGF8 CHRNA4	1.03e-04	80	69	4	CID000051605
Drug	drimanial	TRPV2 TRPV3	1.35e-04	6	69	2	CID000636975
Drug	isovelleral	TRPV2 TRPV3	1.88e-04	7	69	2	CID000037839
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	CFLAR TRIB3 FASTK ZNF335 ERN2	1.96e-04	176	69	5	2639_DN
Drug	Scoulerine [6451-73-6]; Up 200; 12.2uM; HL60; HG-U133A	CFLAR FASTK ZBTB40 CPD ERN2	2.73e-04	189	69	5	1742_UP
Drug	Acacetin [480-44-4]; Down 200; 14uM; HL60; HT_HG-U133A	HIVEP3 SP100 FASTK SAFB2 ERN2	2.80e-04	190	69	5	2189_DN
Drug	Mitoxantrone dihydrochloride [70476-82-3]; Up 200; 7.8uM; MCF7; HT_HG-U133A	RPL10L SP100 FGF8 CACNA1G HUWE1	2.80e-04	190	69	5	3232_UP
Drug	Muramic acid, N-acetyl [10597-89-4]; Down 200; 13.6uM; PC3; HT_HG-U133A	CFLAR PHLDB1 NOL6 POGZ ATM	2.80e-04	190	69	5	4582_DN
Drug	Kawain [500-64-1]; Down 200; 17.4uM; MCF7; HT_HG-U133A	CFLAR PHLDB1 POGZ ATM ERN2	2.80e-04	190	69	5	2299_DN
Drug	LY294002; Up 200; 10uM; MCF7; HG-U133A	HIVEP3 FASTK ZFYVE26 EIF2AK1 ERN2	2.80e-04	190	69	5	328_UP
Drug	Ethopropazine hydrochloride [1094-08-2]; Up 200; 11.4uM; MCF7; HT_HG-U133A	HIVEP3 SP100 TRIB3 KLF9 ERN2	2.87e-04	191	69	5	5296_UP
Drug	Benzylpenicillin sodium [69-57-8]; Down 200; 11.2uM; MCF7; HT_HG-U133A	CFLAR BCL11B SAFB2 POGZ ATM	2.87e-04	191	69	5	6839_DN
Drug	Guanfacine hydrochloride [29110-48-3]; Down 200; 14.2uM; MCF7; HT_HG-U133A	CFLAR KLF9 CPD ATM ERN2	2.87e-04	191	69	5	2634_DN
Drug	Sanguinarine [2447-54-3]; Down 200; 12uM; MCF7; HT_HG-U133A	BCL11B ZBTB40 ZFYVE26 CPD ATM	2.87e-04	191	69	5	4168_DN
Drug	wortmannin from Penicillium funiculosum; Up 200; 0.01uM; MCF7; HT_HG-U133A	CFLAR SP100 KLF9 ZBTB40 CPD	2.87e-04	191	69	5	6959_UP
Drug	Estriol [50-27-1]; Down 200; 13.8uM; MCF7; HT_HG-U133A	CFLAR SP100 KLF9 ZNF335 ZFYVE26	2.87e-04	191	69	5	7220_DN
Drug	2-propylpentanoic acid; Down 200; 1000uM; SKMEL5; HG-U133A	CFLAR POLE ZNF335 ZBTB40 POGZ	3.01e-04	193	69	5	629_DN
Drug	barium sulfate	FGF8 SIM1 DNAH11	3.01e-04	43	69	3	CID000024414
Drug	Kynurenine, 3-hydroxy (R,S) [2147-61-7]; Down 200; 17.8uM; MCF7; HT_HG-U133A	RPL10L SP100 FASTK SAFB2 ERN2	3.08e-04	194	69	5	5641_DN
Drug	(-)-Quinpirole hydrochloride [85760-74-3]; Down 200; 15.6uM; MCF7; HT_HG-U133A	HIVEP3 CFLAR PHLDB1 KLF9 ATM	3.08e-04	194	69	5	3539_DN
Drug	Phensuximide [86-34-0]; Down 200; 21.2uM; MCF7; HT_HG-U133A	RPL10L CFLAR PHLDB1 KLF9 ATM	3.08e-04	194	69	5	3521_DN
Drug	Dihydroergotamine tartrate [5989-77-5]; Down 200; 3uM; PC3; HT_HG-U133A	HIVEP3 CFLAR NOL6 POGZ ERN2	3.16e-04	195	69	5	4502_DN
Drug	Fluorometholone [426-13-1]; Up 200; 10.6uM; MCF7; HT_HG-U133A	RPL10L HIVEP3 CFLAR TRIB3 GPR183	3.16e-04	195	69	5	6247_UP
Drug	Hesperidin [520-26-3]; Up 200; 6.6uM; MCF7; HT_HG-U133A	CFLAR SP100 ATM ERN2 DEDD	3.16e-04	195	69	5	5313_UP
Drug	Clozapine [5786-21-0]; Up 200; 12.2uM; MCF7; HT_HG-U133A	HIVEP3 CFLAR ZBTB40 ATM HUWE1	3.16e-04	195	69	5	5265_UP
Drug	F0447-0125; Down 200; 10uM; MCF7; HT_HG-U133A	CFLAR BCL11B SAFB2 ERN2 DNAH9	3.16e-04	195	69	5	6424_DN
Drug	Fluspirilen [1841-19-6]; Up 200; 8.4uM; PC3; HT_HG-U133A	CFLAR HECW1 GDPD3 ATM ERN2	3.16e-04	195	69	5	6662_UP
Drug	Flupentixol dihydrochloride cis-(Z) [2413-38-9]; Down 200; 7.8uM; MCF7; HT_HG-U133A	CFLAR SP100 ZNF335 CPD METTL17	3.16e-04	195	69	5	5307_DN
Drug	Promazine hydrochloride [53-60-1]; Down 200; 12.4uM; HL60; HT_HG-U133A	RPL10L FASTK GDPD3 SAFB2 ERN2	3.16e-04	195	69	5	2173_DN
Drug	rofecoxib; Up 200; 10uM; MCF7; HG-U133A	HECW1 EGR4 NOL6 ZBTB40 ERN2	3.16e-04	195	69	5	166_UP
Drug	15d-PGJ2; Up 200; 10uM; SKMEL5; HG-U133A	CFLAR PHLDB1 HECW1 ATM ERN2	3.16e-04	195	69	5	564_UP
Drug	Ursolic acid [77-52-1]; Down 200; 8.8uM; PC3; HT_HG-U133A	CFLAR SP100 SAFB2 ATM DEDD	3.16e-04	195	69	5	5825_DN
Drug	estradiol, USP; Up 200; 0.01uM; MCF7; HT_HG-U133A	HIVEP3 CFLAR SP100 KLF9 ZBTB40	3.23e-04	196	69	5	1666_UP
Drug	Cephalexin monohydrate [23325-78-2]; Down 200; 11uM; MCF7; HT_HG-U133A	RPL10L CFLAR FASTK KLF9 ERN2	3.23e-04	196	69	5	5615_DN
Drug	Meticrane [1084-65-7]; Down 200; 14.6uM; MCF7; HT_HG-U133A	CFLAR SP100 ATM EIF2AK1 ERN2	3.23e-04	196	69	5	5984_DN
Drug	Phenacetin [62-44-2]; Up 200; 22.4uM; PC3; HT_HG-U133A	RPL10L HECW1 LRP1 CACNA1G GPR183	3.23e-04	196	69	5	3992_UP
Drug	Sulfadoxine [2447-57-6]; Up 200; 12.8uM; MCF7; HT_HG-U133A	PHLDB1 BCL11B CPD ATM EIF2AK1	3.23e-04	196	69	5	7205_UP
Drug	Diflunisal [22494-42-4]; Up 200; 16uM; HL60; HG-U133A	HIVEP3 CFLAR ZNF335 TRPV2 GPR183	3.23e-04	196	69	5	1990_UP
Drug	Atropine-N-oxide hydrochloride [4574-60-1]; Down 200; 11.8uM; HL60; HG-U133A	HIVEP3 HECW1 ZBTB40 POGZ ATM	3.23e-04	196	69	5	1370_DN
Drug	GBR 12909 dihydrochloride [67469-78-7]; Up 200; 7.6uM; HL60; HG-U133A	CFLAR FASTK ZBTB40 CPD GPR183	3.23e-04	196	69	5	1625_UP
Drug	Dantrolene sodium salt [14663-23-1]; Down 200; 11.8uM; MCF7; HT_HG-U133A	CFLAR CPD POGZ ATM ERN2	3.23e-04	196	69	5	2329_DN
Drug	Diphemanil methylsulfate [62-97-5]; Down 200; 10.2uM; PC3; HT_HG-U133A	SP100 NOL6 SAFB2 LRP1 ERN2	3.23e-04	196	69	5	4591_DN
Drug	Papaverine hydrochloride [61-25-6]; Down 200; 10.6uM; MCF7; HT_HG-U133A	CFLAR SP100 ZBTB40 ATM EIF2AK1	3.23e-04	196	69	5	6245_DN
Drug	Spiramycin [8025-81-8]; Down 200; 4.8uM; PC3; HT_HG-U133A	RPL10L HIVEP3 SP100 CPD ERN2	3.23e-04	196	69	5	3762_DN
Drug	Calycanthine [595-05-1]; Down 200; 11.6uM; MCF7; HT_HG-U133A	CFLAR ZNF335 CPD ATM ERN2	3.23e-04	196	69	5	2764_DN
Drug	0173570-0000 [211245-44-2]; Up 200; 1uM; MCF7; HT_HG-U133A	RPL10L CFLAR SP100 PHLDB1 ATM	3.31e-04	197	69	5	4715_UP
Drug	Guaifenesin [93-14-1]; Up 200; 20.2uM; MCF7; HT_HG-U133A	SP100 PHLDB1 ZNF335 ATM ERN2	3.31e-04	197	69	5	3431_UP
Drug	Pilocarpine nitrate [148-72-1]; Down 200; 14.8uM; MCF7; HT_HG-U133A	HIVEP3 CFLAR SP100 KLF9 ATM	3.31e-04	197	69	5	3300_DN
Drug	LY 294002; Down 200; 0.1uM; MCF7; HT_HG-U133A	PHLDB1 BCL11B SAFB2 ATM EIF2AK1	3.31e-04	197	69	5	5576_DN
Drug	Ciprofloxacin hydrochloride [93107-08-5]; Up 200; 10.8uM; HL60; HG-U133A	PHLDB1 FASTK KLF9 GDPD3 DEDD	3.31e-04	197	69	5	2022_UP
Drug	Benzydamine hydrochloride [132-69-4]; Down 200; 11.6uM; PC3; HT_HG-U133A	HIVEP3 NOL6 SAFB2 POGZ ATM	3.31e-04	197	69	5	5811_DN
Drug	Sulfamethoxazole [723-46-6]; Up 200; 15.8uM; MCF7; HT_HG-U133A	RPL10L CFLAR PHLDB1 SAFB2 ATM	3.31e-04	197	69	5	4690_UP
Drug	Glipizide [29094-61-9]; Down 200; 9uM; MCF7; HT_HG-U133A	CFLAR KLF9 SAFB2 ATM ERN2	3.31e-04	197	69	5	1508_DN
Drug	Trimethobenzamide hydrochloride [554-92-7]; Down 200; 9.4uM; HL60; HG-U133A	CFLAR FASTK POLE ZBTB40 ATM	3.38e-04	198	69	5	2002_DN
Drug	Ampicillin trihydrate [7177-48-2]; Down 200; 10uM; MCF7; HT_HG-U133A	CFLAR FASTK KLF9 SAFB2 ZFYVE26	3.38e-04	198	69	5	1530_DN
Drug	Theophylline monohydrate [5967-84-0]; Down 200; 20.2uM; MCF7; HT_HG-U133A	RPL10L HIVEP3 PHLDB1 SAFB2 ATM	3.38e-04	198	69	5	3326_DN
Drug	Meclocycline sulfosalicylate [73816-42-9]; Up 200; 5.8uM; PC3; HT_HG-U133A	PHLDB1 BCL11B CACNA1G ATM CHRNA4	3.38e-04	198	69	5	6637_UP
Drug	Delcorine; Up 200; 8.4uM; MCF7; HT_HG-U133A	HIVEP3 SP100 HECW1 KLF9 HUWE1	3.38e-04	198	69	5	6033_UP
Drug	Tolnaftate [2398-96-1]; Down 200; 13uM; MCF7; HT_HG-U133A	HIVEP3 CFLAR CPD ATM ERN2	3.38e-04	198	69	5	4805_DN
Drug	Ketorolac tromethamine [74103-07-4]; Down 200; 10.6uM; MCF7; HT_HG-U133A	HIVEP3 CFLAR FASTK ZFYVE26 CPD	3.38e-04	198	69	5	6489_DN
Drug	S(+)-Terguride [37686-84-3]; Down 200; 11.8uM; MCF7; HT_HG-U133A	HIVEP3 KLF9 CPD POGZ ATM	3.38e-04	198	69	5	6459_DN
Drug	Dyclonine hydrochloride [536-43-6]; Down 200; 12.2uM; HL60; HT_HG-U133A	HIVEP3 SP100 TRPV2 ZBTB40 ERN2	3.38e-04	198	69	5	2392_DN
Drug	THIP Hydrochloride; Down 200; 22.6uM; PC3; HT_HG-U133A	CFLAR PHLDB1 NOL6 SAFB2 EIF2AK1	3.38e-04	198	69	5	7266_DN
Drug	Alprenolol hydrochloride [13707-88-5]; Down 200; 14uM; HL60; HG-U133A	CFLAR TRPV2 CPD POGZ ATM	3.38e-04	198	69	5	1571_DN
Drug	Tremorine dihydrochloride [300-68-5]; Down 200; 15uM; MCF7; HT_HG-U133A	HIVEP3 SP100 ZNF335 ZBTB40 ATM	3.38e-04	198	69	5	3196_DN
Drug	Vincamine [1617-90-9]; Up 200; 11.2uM; MCF7; HT_HG-U133A	PHLDB1 HECW1 EGR4 CACNA1G GPR183	3.38e-04	198	69	5	3976_UP
Drug	Streptomycin sulfate [3810-74-0]; Down 200; 2.8uM; PC3; HT_HG-U133A	SP100 SAFB2 ATM ERN2 DEDD	3.38e-04	198	69	5	5837_DN
Drug	Promethazine hydrochloride [58-33-3]; Down 200; 12.4uM; MCF7; HT_HG-U133A	SP100 BCL11B KLF9 CPD ATM	3.46e-04	199	69	5	6477_DN
Drug	Nortriptyline hydrochloride [894-71-3]; Down 200; 13.4uM; MCF7; HT_HG-U133A	CFLAR PHLDB1 SAFB2 CPD ATM	3.46e-04	199	69	5	7422_DN
Drug	Pridinol methanesulfonate salt [6856-31-1]; Up 200; 10.2uM; MCF7; HT_HG-U133A	CFLAR PHLDB1 BCL11B KLF9 CACNA1G	3.46e-04	199	69	5	7214_UP
Drug	Clorsulon [60200-06-8]; Down 200; 10.6uM; MCF7; HT_HG-U133A	FASTK GDPD3 ZNF335 SAFB2 ZBTB40	3.46e-04	199	69	5	7025_DN
Drug	Suxibuzone [27470-51-5]; Up 200; 9.2uM; MCF7; HT_HG-U133A	CFLAR PHLDB1 KLF9 ATM ERN2	3.46e-04	199	69	5	7163_UP
Drug	sodium 4-phenylbutyrate; Down 200; 1000uM; MCF7; HG-U133A	CYSLTR2 FASTK KLF9 ZNF335 CPD	3.46e-04	199	69	5	408_DN
Drug	Dichlorphenamide [120-97-8]; Up 200; 13.2uM; MCF7; HT_HG-U133A	CFLAR POGZ ATM EIF2AK1 ERN2	3.46e-04	199	69	5	5286_UP
Disease	Intellectual Disability	BCL11B NSF ZNF335 ZBTB40 CACNA1G POGZ	4.54e-04	447	65	6	C3714756
Disease	response to platinum based chemotherapy, magnesium measurement	PCDH15 CHRNA4	4.93e-04	15	65	2	EFO_0004647, EFO_0004845
Disease	Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse	WNT10A ATM	5.62e-04	16	65	2	C0334634
Disease	Benign neoplasm of stomach	POLE ATM	6.36e-04	17	65	2	C0153943
Disease	Neoplasm of uncertain or unknown behavior of stomach	POLE ATM	6.36e-04	17	65	2	C0496905
Disease	Carcinoma in situ of stomach	POLE ATM	6.36e-04	17	65	2	C0154060
Disease	Stomach Carcinoma	POLE ATM	9.77e-04	21	65	2	C0699791
Disease	lung squamous cell carcinoma (is_implicated_in)	POLE ATM	1.28e-03	24	65	2	DOID:3907 (is_implicated_in)
Disease	breast carcinoma	HIVEP3 CFLAR NSF SYT6 NOL6 CREB5 ANKRD16 DNAH11	1.74e-03	1019	65	8	EFO_0000305
Disease	prostate carcinoma in situ (is_marker_for)	CARM1 ATM	1.74e-03	28	65	2	DOID:8634 (is_marker_for)
Disease	Dupuytren Contracture	BCL11B MROH1 ZBTB40	1.77e-03	108	65	3	EFO_0004229

Protein segments in the cluster

Peptide	Gene	Start	Entry
RHSIRDRKPSLHFLH	nan	26	A8MVM7
FVLNVHHRSPRTHTM	CHRNA4	326	P43681
RRTPLHTAAMHGHLE	ANKRD16	171	Q6P6B7
TPFMRLLFEIHHLRS	DNAH11	2291	Q96DT5
LHRMFDIVGTHLTHR	DEDD	26	O75618
EHLHGQFLHSLRLAM	HSD11B2	301	P80365
QTHSGLPLHHIRRMF	CFLAR	326	O15519
HARRHTEFHPSMIKR	KLF9	221	Q13886
RFPTEDHLMIHRHKH	CREB5	26	Q02930
TPHVMVLLAQHLARH	FASTK	236	Q14296
HVRAHLRMKACHTLP	DCDC1	1101	M0R2J8
PRTHYIRIHTLLHSM	HECW1	556	Q76N89
TLHRPMDLHVFHALR	LRP1	3271	Q07954
FPRLLLHTHRAMRSC	ERN2	886	Q76MJ5
MAEPGHSHHLSARVR	ELAPOR1	1	Q6UXG2
DLHRIEIPFKFHMLH	CARM1	366	Q86X55
MIRAFDHVLHLRPLS	NOL6	466	Q9H6R4
FRFHHQPMIISRHLP	NPIPB5	616	A8MRT5
ILHIHTARMRGHQLL	NSF	406	P46459
AMLSIFFLRRPHLLH	GDPD3	16	Q7L5L3
LLHDPALHRTLHNMM	POLE	1831	Q07864
APHSRRRAMLHLSEF	EGR4	96	Q05215
HLMHHFPDLLGRLLT	MROH1	1556	Q8NDA8
HPLMVRHADHSSLTL	HUWE1	2516	Q7Z6Z7
RFFHMHPRTAELSLL	PCDH15	336	Q96QU1
HFMKRLPRGHHTTEQ	FGF8	191	P55075
SRISMDHPHHTLFII	ATM	2546	Q13315
LHLHARLALLRHMAE	FBF1	1091	Q8TES7
PRHHLDPHRLSAEEM	BCL11B	321	Q9C0K0
RLLCHRIITHKMFDH	CACNA1G	1266	O43497
LRLHHNRAITHLMRS	EIF2AK1	116	Q9BQI3
FHHHHFPDMEIFLRR	CPD	501	O75976
SIHPHQMLDARHIEI	DNAH9	1251	Q9NYC9
PDGHMQHAVLTARRH	METTL17	406	Q9H7H0
FRFHHQPMIISRHLP	NPIPB13	621	A6NJU9
NSAMIHLIHVDPRLH	OR2L13	41	Q8N349
SVMHRVARHAAPRVH	OR52K1	261	Q8NGK4
MSHHPHSLRNSCLIR	SND1-IT1	1	Q9HBX3
HMRVRLHPFHVIRIN	RPL10L	86	Q96L21
PRFFVHSLHRLRLEM	RPUSD4	346	Q96CM3
HVHPHAFRDLGRLMT	RTN4R	216	Q9BZR6
RHTSFKRHLPRQMHV	SYT6	171	Q5T7P8
ISFHPKRPMHILLHD	UTP4	586	Q969X6
MLRHHLTPHARRAVA	POGZ	1076	Q7Z3K3
HHSTARIVMPLHYSL	GPR183	26	P32249
MESLRHLHPHVGRTL	PPP1R32	391	Q7Z5V6
NSMPHIASVHRIHGR	SIM1	511	P81133
ISSVHRSRHLVMPEH	SAMD11	111	Q96NU1
IVLIRRSHHLHTPMY	OR5P3	46	Q8WZ94
RFLAMVHPFRLLHVT	CYSLTR2	136	Q9NS75
HLRATHHMTELPLRF	LINC02915	51	Q8N8G6
FHKRPGLMAHLLIHT	ZNF610	381	Q8N9Z0
LKLHMRTHTDERPHA	ZSCAN10	336	Q96SZ4
FMALLRRLLPHVHKH	TBC1D10C	226	Q8IV04
HGDMHSLVRSRHRIP	TRIB3	141	Q96RU7
SFTRRPHLEEHMILH	ZBTB41	471	Q5SVQ8
HLPAHSHDLQRMFTE	SP100	26	P23497
LTVPSHHPHAREMRR	HIVEP3	976	Q5T1R4
HHPHAREMRRSASEQ	HIVEP3	981	Q5T1R4
EIIAFHCKSPHRHRM	TRPV2	356	Q9Y5S1
SVLDMLRHFHTHPIP	SH2B2	486	O14492
SHLHRTELHGRMISV	SAFB2	466	Q14151
LMHHSILHHLPAGRE	PHLDB1	1086	Q86UU1
FRLHMHLIRHQKLHT	ZNF780A	566	O75290
RRFHRLHHPMAVDLG	ZNF697	161	Q5TEC3
RHEMLTLEPLHTLLH	TRPV3	416	Q8NET8
RPAHLIRHRMLHTGE	ZNF746	521	Q6NUN9
SREPHRDIHARMRLH	WNT10A	231	Q9GZT5
FHLHVLRRKGEHRMS	ZFAND4	176	Q86XD8
EVRAHMAQHSSLRPH	ZNF335	1061	Q9H4Z2
VHMLVHSPAHVRVRL	UHRF1BP1	816	Q6BDS2
AMSGRNELHSRLHPH	ZFYVE26	806	Q68DK2
RMSFPTLQDHRKHIH	ZBTB40	956	Q9NUA8
MLIVHHRTHTGERPY	ZNF649	416	Q9BS31
RIFLQTLDMHHRHHL	MYO1G	481	B0I1T2